Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profilesKensuke Ochi, Yusuke Nakamura, Yataro Daigo et al.|International Journal of Oncology|2004Cited by 100
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcomaKazuhito Morioka, Koichi Matsuda, Chizu Tanikawa et al.|Cancer Science|2009Cited by 94
Prognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in JapanSatoshi Takenaka, Hideki Yoshikawa, Takafumi Ueda et al.|Oncology Reports|2008Cited by 60
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 studyHiroshi Urakawa, Toshifumi Ozaki, Toshiyuki Kunisada et al.|World Journal of Surgical Oncology|2018Cited by 55